Published on January 28, 2021

Now Offering Monoclonal Antibody COVID-19 Treatment

You may be eligible to receive monoclonal antibody treatment at Bergen New Bridge if you currently have mild to moderate COVID-19 symptoms and are not hospitalized.

This treatment involves a single infusion of antibodies, which are laboratory-made proteins mimicking the immune system’s ability to fight off viruses. Monoclonal antibody treatment is available to those who meet certain high-risk medical requirements. Eligible patients must be treated within ten days of the initial onset of symptoms.

For more information or to be scheduled for a treatment evaluation, call 201.225.7130

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.